Bank of America has significantly increased its price targets for major stocks ahead of Q2 earnings reports, boosting Apple's target to $325, Eli Lilly's to $1,294, and AbbVie's to $234. These revisions reflect strong expectations for iPhone sales and potential upside for Eli Lilly, despite competitive challenges. However, the firm remains cautious, warning of possible bubble risks in the technology sector, which could influence market stability in the coming months.
Click a month on the chart to update the report below.
%20-%20USA%20-%20UNOCHA.svg&width=160)
